Subjective Well Being of Patients Receiving Atypical Antipsychotics as Monotherapy or Cotherapy With Mood Stabilizers

计划入组 540 人 · 首次发布于 2008 年 6 月 5 日

Study of VX-661 Alone and in Combination With Ivacaftor in Subjects Homozygous or Heterozygous to the F508del-Cystic Fibrosis Transmembrane Conductance Regulator(CFTR) Mutation

计划入组 194 人 · 首次发布于 2012 年 2 月 13 日

Cath Lab Performance Improvement

首次发布于 2006 年 1 月 18 日

Dimethoxanate

C₁₉H₂₂N₂O₃S

COTI-58

COTI-4A

Cotherix, Inc.

United States

Cota & Cota, Inc.

United States

Cota

Breakthrough Humanized Antibody VX-01 Shows Promise Against Deadly Mucormycosis

Cothera Bioscience's PC-002 Receives FDA Fast Track for Burkitt Lymphoma

FDA Grants Fast Track Designation to Zotiraciclib for IDH-Mutant Recurrent High-Grade Glioma